Atwood & Palmer’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $71.3K | Hold |
912
| – | – | ﹤0.01% | 216 |
|
2025
Q1 | $66.1K | Hold |
912
| – | – | ﹤0.01% | 206 |
|
2024
Q4 | $67.5K | Hold |
912
| – | – | ﹤0.01% | 205 |
|
2024
Q3 | $60.2K | Hold |
912
| – | – | ﹤0.01% | 211 |
|
2024
Q2 | $84.2K | Hold |
912
| – | – | 0.01% | 197 |
|
2024
Q1 | $87.2K | Hold |
912
| – | – | 0.01% | 193 |
|
2023
Q4 | $69.5K | Hold |
912
| – | – | 0.01% | 207 |
|
2023
Q3 | $63.2K | Hold |
912
| – | – | 0.01% | 202 |
|
2023
Q2 | $86K | Hold |
912
| – | – | 0.01% | 197 |
|
2023
Q1 | $75.5K | Hold |
912
| – | – | 0.01% | 188 |
|
2022
Q4 | $68K | Hold |
912
| – | – | 0.01% | 196 |
|
2022
Q3 | $75K | Sell |
912
-202
| -18% | -$16.6K | 0.01% | 183 |
|
2022
Q2 | $106K | Buy |
1,114
+202
| +22% | +$19.2K | 0.01% | 162 |
|
2022
Q1 | $107K | Hold |
912
| – | – | 0.01% | 175 |
|
2021
Q4 | $118K | Hold |
912
| – | – | 0.01% | 174 |
|
2021
Q3 | $103K | Hold |
912
| – | – | 0.01% | 185 |
|
2021
Q2 | $94K | Hold |
912
| – | – | 0.01% | 189 |
|
2021
Q1 | $76K | Hold |
912
| – | – | 0.01% | 196 |
|
2020
Q4 | $83K | Hold |
912
| – | – | 0.01% | 183 |
|
2020
Q3 | $73K | Hold |
912
| – | – | 0.01% | 173 |
|
2020
Q2 | $63K | Hold |
912
| – | – | 0.01% | 177 |
|
2020
Q1 | $57K | Hold |
912
| – | – | 0.01% | 172 |
|
2019
Q4 | $71K | Hold |
912
| – | – | 0.01% | 169 |
|
2019
Q3 | $67K | Hold |
912
| – | – | 0.01% | 178 |
|
2019
Q2 | $56K | Hold |
912
| – | – | 0.01% | 170 |
|
2019
Q1 | $58K | Hold |
912
| – | – | 0.01% | 169 |
|
2018
Q4 | $47K | Hold |
912
| – | – | 0.01% | 172 |
|
2018
Q3 | $53K | Hold |
912
| – | – | 0.01% | 178 |
|
2018
Q2 | $44K | Hold |
912
| – | – | 0.01% | 184 |
|
2018
Q1 | $42K | Hold |
912
| – | – | 0.01% | 185 |
|
2017
Q4 | $34K | Hold |
912
| – | – | ﹤0.01% | 197 |
|
2017
Q3 | $33K | Hold |
912
| – | – | ﹤0.01% | 199 |
|
2017
Q2 | $36K | Hold |
912
| – | – | 0.01% | 202 |
|
2017
Q1 | $29K | Buy |
912
+312
| +52% | +$9.92K | ﹤0.01% | 198 |
|
2016
Q4 | $19K | Buy |
+600
| New | +$19K | ﹤0.01% | 233 |
|